Rognoni C, Bertolani A, Jommi C. Budget impact analysis of rituximab biosimilar in Italy from the hospital and payer perspectives. Grhta [Internet]. 2018 Jun. 29 [cited 2024 Jul. 3];5(1). Available from: https://journals.aboutscience.eu/index.php/grhta/article/view/440